Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.
Journal: Journal for immunotherapy of cancer
Published: May 21, 2026
Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety.
Journal: Blood cancer journal
Published: February 24, 2026
Feasibility and Safety of a Novel CD19-Directed CAR T-Cell Therapy in Patients with R/R B-Cell Non-Hodgkin Lymphoma.
Journal: Transplantation and cellular therapy
Published: February 23, 2026
Pharmacokinetic and pharmacodynamic characterization of CD8-targeted lentiviral vector for in vivo CD19-directed CAR-T therapy.
Journal: Molecular therapy. Advances
Published: November 17, 2025
Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survival.
Journal: Journal for immunotherapy of cancer
Published: October 29, 2025
Hypoxia-regulatable CAR T cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cells.
Journal: Molecular therapy. Advances
Published: May 21, 2025
Reduced CCL/Be-specific CD4+ T cells in CCL3-deficient or peptide-MHCII CAR-T cell-treated mice.
Journal: JCI insight
Published: May 21, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
Journal: Cytotherapy
Published: May 06, 2025
Last Updated: 09/26/2026